Chromatography Column High Loading for Radioactive Eluate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing radioactive solutions, such as those used in angioplasty, require high specific activity tungsten-188, which is costly and difficult to produce, necessitating either high specific activity tungsten or complex fractionation/concentration processes to achieve suitable specific activity for medical applications.
Innovation Solution
A method and device involving a chromatography column with a stationary phase where the mother nuclide is adsorbed at or above 40% of the maximum absorption capacity, allowing for elution of the daughter nuclide with a significantly smaller eluate volume without additional fractionation or concentration, using tungsten with lower specific activity and optimizing parameters like loading time, pH, and oxidation state.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If high specific activity tungsten-188 is used, then high specific activity rhenium-188 eluate can be obtained, but production costs increase and production difficulty increases
Solution Approach 1:
The patent changes the parameter of mother nuclide loading amount from the conventional low loading (5-20% of maximum absorption capacity) to high loading (at least 40% of maximum absorption capacity). This parameter change allows the system to achieve high specific activity in the eluate not through high specific activity input material, but through optimized distribution and elution dynamics, thereby resolving the contradiction between manufacturing precision and ease of manufacture.
2Manufacturing precision
If high specific activity tungsten-188 is used, then high specific activity rhenium-188 eluate can be obtained, but production costs increase
Solution Approach 1:
By changing the loading amount parameter to high loading (at least 40% of maximum absorption capacity), the patent enables the use of tungsten-188 with lower specific activity (5-6 Ci/g) to produce eluates with sufficiently high specific activity (4-9 GBq/ml). This parameter optimization reduces the need for expensive high specific activity input materials, thereby resolving the contradiction between manufacturing precision and quantity of substance.
3Manufacturing precision
If fractional elution is performed, then specific activity of eluate increases, but device complexity and process complexity increase
Solution Approach 1:
The patent simplifies the elution process by using a single elution step with optimized high loading conditions rather than multiple fractional elution steps. The high loading amount (at least 40% of maximum absorption capacity) creates favorable elution dynamics that achieve high specific activity in a straightforward single-step process, thereby resolving the contradiction between manufacturing precision and device complexity.
4Quantity of substance
If larger amounts of tungsten with low specific activity are used, then more total activity can be obtained, but specific activity of eluate decreases
Solution Approach 1:
The patent resolves this contradiction by optimizing the loading amount parameter to high loading (at least 40% of maximum absorption capacity). This optimization creates an optimal ratio between the amount of mother nuclide and the eluate volume, allowing the system to maintain high specific activity in the eluate even when using larger amounts of tungsten with lower specific activity. The high loading enables efficient utilization of the available activity while controlling eluate volume to preserve specific activity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces production costs and extends the time between refills while achieving high specific activity rhenium-188 solutions for medical applications without additional processing, using tungsten with lower tungsten-188 content and allowing for higher specific activity eluates without fractionation or concentration.
Implementation Method 1
a mother nuclide adsorbed thereon, the amount of the mother nuclide adsorbed being at least 40% of the maximum absorption capacity of the stationary phase
Implementation Method 2
a generator for radioactive substances... a chromatography column with a stationary phase where the mother nuclide is adsorbed... allowing for elution of the daughter nuclide
Implementation Method 3
Rhenium-188 can be obtained easily and without carrier materials from the decay of the long-lived mother nuclide tungsten-188
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The procedure for the production of radioactive daughter nuclide for medical applications, comprises allocating a generator with a chromatography column (3) having a stationary phase and an adsorbed mother nuclide at the stationary phase, eluting the daughter nuclides from the column with 0.9% of sodium chloride solution as solvent, filling the column with mother nuclides in a solution, oxidizing the solution with hydrogen peroxide and then acidifying with hydrochloric acid. The quantity of the adsorbed mother nuclides is 10% of the maximum adsorption capacity of the stationary phase. The procedure for the production of a radioactive daughter nuclide for medical applications, comprises allocating a generator with a chromatography column (3) having a stationary phase and an adsorbed mother nuclide at the stationary phase, eluting the daughter nuclides from the chromatography column with 0.9% of sodium chloride solution as solvent, filling the column with mother nuclides in a solution, oxidizing the solution with hydrogen peroxide and then acidifying with hydrochloric acid. The quantity of the adsorbed mother nuclides is 10% of the maximum adsorption capacity of the stationary phase. The chromatography column is filled with oxides of aluminum, zirconium, manganese or titanium or its mixture. The mother nuclide is tungston-188 in an acidic solution of sodium tungstate (Na 2 1> 8> 8>WO 4) that decomposes in rhenium-188. An independent claim is included for a generator for radioactive substances with a chromatography column.